SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-18-012327
Filing Date
2018-11-09
Accepted
2018-11-09 16:41:45
Documents
74
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT azrx10q_sep302018.htm 10-Q 1039695
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-1.htm EX-31.1 16928
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-2.htm EX-31.2 16924
4 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE ex32-1.htm EX-32.1 9655
  Complete submission text file 0001654954-18-012327.txt   3612926

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT azrx-20180930.xml EX-101.INS 546804
6 XBRL TAXONOMY EXTENSION SCHEMA azrx-20180930.xsd EX-101.SCH 48171
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE azrx-20180930_cal.xml EX-101.CAL 49776
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE azrx-20180930_def.xml EX-101.DEF 109814
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE azrx-20180930_lab.xml EX-101.LAB 254051
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE azrx-20180930_pre.xml EX-101.PRE 210288
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-37853 | Film No.: 181173652
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1